Recent studies have revealed that the overexpression of HMGA2 correlates with higher lymph node metastasis rates, poor tumor differentiation, and unfavorable prognosis [10–14], implying that HMGA2 has prognostic value in cancer. This evidence concerns the gene HMGA2 and cancer.